XBIO
Income statement / Annual
Last year (2023), Xenetic Biosciences, Inc.'s total revenue was $2.54 M,
an increase of 48.80% from the previous year.
In 2023, Xenetic Biosciences, Inc.'s net income was -$4.13 M.
See Xenetic Biosciences, Inc.,s key income statements, including revenue, expenses, profit, and income.
Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
Operating Revenue |
$2.54 M |
$1.71 M |
$1.16 M |
$436,942.00 |
$17,066.00 |
$0.00 |
$7.59 M |
$3.00 M |
$0.00 |
$0.00 |
Cost of Revenue |
$0.00
|
$27,043.00
|
$35,482.00
|
$0.00
|
$0.00
|
$15,827.00
|
$156,119.00
|
$36,449.00
|
$56,115.00
|
$0.00
|
Gross Profit |
$2.54 M
|
$1.68 M
|
$1.13 M
|
$436,942.00
|
$17,066.00
|
-$15,827.00
|
$7.43 M
|
$2.96 M
|
-$56,115.00
|
$0.00
|
Gross Profit Ratio |
1
|
0.98
|
0.97
|
1
|
1
|
0
|
0.98
|
0.99
|
0
|
0
|
Research and Development Expenses |
$3.49 M
|
$4.77 M
|
$3.16 M
|
$1.73 M
|
$4.89 M
|
$2.88 M
|
$4.06 M
|
$43.74 M
|
$3.43 M
|
$6.32 M
|
General & Administrative Expenses |
$3.56 M
|
$3.65 M
|
$3.74 M
|
$3.40 M
|
$4.73 M
|
$4.39 M
|
$6.94 M
|
$6.69 M
|
$6.39 M
|
$6.60 M
|
Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
Selling, General & Administrative Expenses |
$3.56 M
|
$3.65 M
|
$3.74 M
|
$3.40 M
|
$4.73 M
|
$4.39 M
|
$6.94 M
|
$6.69 M
|
$6.39 M
|
$6.60 M
|
Other Expenses |
$0.00
|
-$1,597.00
|
$1,119.00
|
-$492.00
|
$3,315.00
|
-$24,640.00
|
-$41,096.00
|
$0.00
|
$0.00
|
$0.00
|
Operating Expenses |
$7.06 M
|
$8.42 M
|
$6.91 M
|
$5.13 M
|
$9.62 M
|
$7.28 M
|
$11.00 M
|
$50.43 M
|
$9.82 M
|
$12.92 M
|
Cost And Expenses |
$7.06 M
|
$8.42 M
|
$6.91 M
|
$5.13 M
|
$9.62 M
|
$7.28 M
|
$11.15 M
|
$50.43 M
|
$9.82 M
|
$12.92 M
|
Interest Income |
$355,757.00
|
$167,152.00
|
$100,467.00
|
$126,171.00
|
$216,978.00
|
$0.00
|
$16,544.00
|
$32.00
|
$1,694.00
|
$18,959.00
|
Interest Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$24,131.00
|
$1,818.00
|
$729,572.00
|
$266,999.00
|
$4,706.00
|
Depreciation & Amortization |
-$28,208.00
|
$27,043.00
|
$35,482.00
|
$28,837.00
|
$27,487.00
|
$15,827.00
|
$23,784.00
|
$36,449.00
|
$56,115.00
|
$88,689.00
|
EBITDA |
-$4.54 M |
-$6.72 M |
-$5.71 M |
-$4.69 M |
-$9.58 M |
-$7.26 M |
-$3.57 M |
-$53.44 M |
-$9.77 M |
-$14.21 M |
EBITDA Ratio |
-1.79
|
-3.92
|
-4.92
|
10.48
|
-368.72
|
0
|
-0.47
|
-15.8
|
0
|
0
|
Operating Income Ratio |
-1.78
|
-3.94
|
-4.95
|
10.41
|
-755.12
|
0
|
-0.47
|
-15.81
|
0
|
0
|
Total Other Income/Expenses Net |
$381,137.00
|
$165,555.00
|
$101,586.00
|
$125,679.00
|
$111,804.00
|
-$24,131.00
|
-$26,370.00
|
-$6.78 M
|
-$2.69 M
|
-$1.38 M
|
Income Before Tax |
-$4.13 M
|
-$6.55 M
|
-$5.65 M
|
-$13.81 M
|
-$12.78 M
|
-$7.30 M
|
-$3.60 M
|
-$54.21 M
|
-$12.51 M
|
-$14.31 M
|
Income Before Tax Ratio |
-1.63
|
-3.84
|
-4.86
|
-31.61
|
-748.57
|
0
|
-0.47
|
-18.07
|
0
|
0
|
Income Tax Expense |
$0.00
|
-$165,555.00
|
-$100,467.00
|
-$2.92 M
|
$3.17 M
|
$24,131.00
|
$26,370.00
|
$6.05 M
|
$2.42 M
|
$1.40 M
|
Net Income |
-$4.13 M
|
-$6.39 M
|
-$5.54 M
|
-$10.89 M
|
-$15.95 M
|
-$7.30 M
|
-$3.60 M
|
-$54.21 M
|
-$12.51 M
|
-$14.31 M
|
Net Income Ratio |
-1.63
|
-3.74
|
-4.78
|
-24.93
|
-934.6
|
0
|
-0.47
|
-18.07
|
0
|
0
|
EPS |
-2.71 |
-4.49 |
-5.39 |
-17.04 |
-55.92 |
-96.58 |
-49.78 |
-875.41 |
-355.34 |
-416.91 |
EPS Diluted |
-2.71 |
-4.49 |
-5.39 |
-17.04 |
-55.92 |
-96.57 |
-49.78 |
-875.41 |
-355.34 |
-416.91 |
Weighted Average Shares Out |
$1.53 M
|
$1.42 M
|
$1.03 M
|
$639,238.00
|
$285,246.00
|
$75,590.00
|
$72,214.00
|
$61,921.00
|
$35,199.00
|
$34,317.00
|
Weighted Average Shares Out Diluted |
$1.53 M
|
$1.42 M
|
$1.03 M
|
$639,238.00
|
$285,246.00
|
$75,601.00
|
$72,214.00
|
$61,921.00
|
$35,199.00
|
$34,317.00
|
Link |
|
|
|
|
|
|
|
|
|
|